Craniopharyngioma

This is a type of brain tumor that grows near the pituitary gland. It can cause headaches, vision problems, and growth issues, especially in children.

Condition

What people with Craniopharyngioma report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Craniopharyngioma?

NameHow it went

About Craniopharyngioma

What It Is

Craniopharyngioma is a rare, slow-growing tumor at the base of the brain. It forms next to the pituitary gland, the pea-sized gland that directs most of the body's hormones, and the hypothalamus, the area just above it that regulates hunger, thirst, body temperature, sleep and hormone signals. The tumor is benign (not cancer) and does not spread to other parts of the body. It matters because of where it sits: as it grows, it can press on the pituitary, the hypothalamus, the nerves that carry vision, and the fluid spaces inside the brain. Most craniopharyngiomas are partly solid and partly a fluid-filled cyst. They can occur at any age but are most often found in children between about 5 and 14 and in adults between about 50 and 74. There are two types. The adamantinomatous type accounts for about 9 in 10 cases, is the usual type in children, and typically contains cysts and calcium deposits. The papillary type occurs almost only in adults and is mostly solid. The difference matters for treatment, because nearly all papillary tumors carry a gene change that targeted medicines can act on. Although it is benign under the microscope, a craniopharyngioma can grow into nearby tissue and comes back after treatment in about half of people. For that reason it is usually managed as a long-term condition rather than a single operation.

Causes & Risk Factors

Craniopharyngiomas are thought to grow from leftover cells of Rathke's pouch, a small structure in the developing embryo that helps form the pituitary gland. That is the source of older names such as Rathke pouch tumor. Each type is driven by a gene change found in the tumor cells. Adamantinomatous tumors carry a gene change that arises in the tumor itself rather than being inherited. Between 90 and 95 percent of papillary tumors carry a change called BRAF V600E, which switches on a growth signal inside the cells. Inherited cases are exceedingly rare, and no lifestyle, environmental or pregnancy-related risk factor is known.

How It's Diagnosed

Symptoms usually build slowly, often over months, and depend on which structures the tumor presses on. Pressure on the optic chiasm (where the two optic nerves cross) commonly causes loss of side vision in both eyes or blurred vision. Blocked fluid in the brain can cause headaches, often worse in the morning, with nausea, vomiting or unusual sleepiness. Disrupted hormones can cause slowed growth and early or late puberty in children, tiredness, weight gain, missed periods or reduced fertility. Some people develop heavy urination and constant thirst from arginine vasopressin deficiency (formerly called central diabetes insipidus), in which the body lacks the hormone that tells the kidneys to hold on to water. An MRI scan of the brain with gadolinium contrast (a dye injected into a vein) is the main test. It shows the tumor's size, its cysts and how closely it involves the hypothalamus, which strongly shapes treatment choices. A CT scan is often added because it shows the calcium deposits typical of the adamantinomatous type. A visual field test maps how much side vision has been lost and sets a baseline for later comparison. Blood and urine tests check pituitary hormones, including cortisol, thyroid hormone, growth hormone, sex hormones and water balance, because missing hormones may need replacing before surgery. The diagnosis is confirmed when a pathologist examines tumor tissue removed during surgery or a biopsy. Tissue from a papillary tumor can be tested for the BRAF change. Imaging also helps separate craniopharyngioma from look-alikes in the same area, such as Rathke cleft cysts, pituitary adenomas and germ cell tumors.

Treatment Options

Treatment is planned by a team that usually includes a neurosurgeon, an endocrinologist (hormone specialist), a radiation oncologist and an eye specialist, with a pediatric oncologist for children. The aim is to control the tumor while protecting the hypothalamus, because damage there causes some of the most lasting problems. For that reason, removing every piece of tumor is not always the goal. Surgery is the usual first step. Surgeons may reach the tumor through the nose (transsphenoidal or endoscopic surgery) or through an opening in the skull (craniotomy). When the tumor is small and separate from the hypothalamus, complete removal may be possible and may be all that is needed. When it is attached to the hypothalamus, surgeons often remove part of it and leave the rest. Extensive removal raises the risk of hypothalamic damage, and in studies of children, complete removal has been linked to worse long-term quality of life than partial removal. Radiation therapy treats tumor left after surgery or tumor that grows back. Focused methods such as proton therapy, intensity-modulated radiation and, for small tumors, stereotactic radiosurgery (a precisely aimed high dose) limit the dose to nearby brain, nerves and vessels. Radiation can still affect growth, development and memory in children, and long-term risks include blood vessel problems, stroke and, rarely, a new tumor. For a tumor that is mostly cyst, a surgeon can place a thin tube to drain the fluid into a small reservoir under the scalp. Medicine, such as the chemotherapy drug bleomycin, or radioactive material can be placed inside the cyst to slow refilling. For papillary tumors with the BRAF change, a combination of BRAF and MEK inhibitors (targeted pills that block the growth signal) can shrink the tumor dramatically. In a small trial of 16 adults, the tumor shrank substantially in all but one, typically by about 90 percent. Side effects such as rash were common, some people stopped because of them, and some tumors grew again after treatment stopped. How long to take these medicines and whether to use them before surgery are still being studied. For the adamantinomatous type, drug treatments are available only in clinical trials. Most people need hormone replacement, often lifelong and with several medicines. Hydrocortisone replaces cortisol, the stress hormone, and is started before other hormones. Other options include thyroid hormone, growth hormone for children, sex hormones to start puberty or maintain bone health, and desmopressin, a man-made version of the water-balance hormone. For weight gain caused by hypothalamic damage (acquired hypothalamic obesity), setmelanotide (Imcivree), a daily injection that acts on the brain's appetite pathway, is FDA-approved for people aged 4 and older.

What to Expect

Survival is generally good: in children, about 9 in 10 are alive five years after diagnosis. The larger challenge is living with the effects of the tumor and its treatment, which can last for decades. Hormone deficiencies are common and usually permanent. With reliable daily replacement, many people attend school, work and live independently, but they need to learn how to manage their medicines, including what to do when they are ill. When the hypothalamus has been affected, people may have intense hunger and rapid weight gain that diet and exercise alone rarely control, along with daytime sleepiness, fatigue, trouble regulating body temperature, and changes in mood, memory and attention. Vision lost before treatment often recovers only partly. These effects vary widely, and they depend mostly on how much the hypothalamus was involved. Follow-up MRI scans continue for years because about half of tumors come back, and regrowth can often be treated again with surgery or radiation. Over the long term, people treated for craniopharyngioma have higher rates of heart disease, metabolic problems and fatty liver disease, so routine care includes checks of weight, blood pressure, blood sugar, cholesterol and liver health. Children benefit from school support and periodic assessments of learning and behavior, and from a planned move from pediatric to adult specialists in their late teens.

When to Seek Help

See a clinician if a child's growth slows or puberty comes unusually early or late, or if anyone has persistent morning headaches, gradual loss of vision or constant thirst and heavy urination without another explanation. After diagnosis, contact the care team promptly about new or worsening headaches, vomiting, unusual sleepiness or new vision changes, which can signal regrowth, a refilling cyst or blocked fluid in the brain. A severe headache with repeated vomiting, drowsiness that makes someone hard to wake, a seizure or sudden loss of vision can mean dangerous pressure in the brain from blocked fluid; call 911. Call right away if you take hydrocortisone and cannot keep it down, or about a marked change in thirst or urine output while taking desmopressin. During illness or before surgery, people on hydrocortisone usually need a temporary higher dose (stress or sick-day dosing) agreed in advance with the endocrinologist. Adrenal crisis, a life-threatening shortage of cortisol, is an emergency for anyone with cortisol deficiency: severe weakness, repeated vomiting, dizziness or fainting, or confusion. Give the emergency hydrocortisone injection if one has been prescribed, and call 911.

Questions to Ask Your Doctor

  1. 1.How involved is the hypothalamus, and how does that change the balance between removing more tumor and protecting it?
  2. 2.Which type of craniopharyngioma is this, and does it carry a gene change that targeted medicine could treat?
  3. 3.Which hormones will need replacing, and what is my plan for sick days and emergencies?
  4. 4.How often will I need MRI scans, eye tests and hormone checks, and who will coordinate them over the long term?
  5. 5.What support is available for weight, sleep, memory or school and work difficulties if they develop?

Last reviewed • Oct 2026

Educational content, not medical advice.